KHK-IN-8
KHK-IN-8 is a selective KHK inhibitor, with an IC50 of 13.0 nM against hKHK-C and an IC50 of 22.7 nM against hKHK-A. KHK-IN-8 is applicable to research on non-alcoholic steatohepatitis, type 2 diabetes and obesity.
For research use only. We do not sell to patients.
- CAS No.: 3108075-72-2
- Formula: C22H24F3N5O2
- Molecular Weight:447.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
hKHK-C 13.0 nM (IC50) |
hKHK-A 22.7 nM (IC50) |
In Vitro
KHK-IN-8 potently inhibits recombinant human KHK-C with an IC50 of 13.0 nM[1].
KHK-IN-8 has an apparent permeability of 23 × 10-6 cm/sec in a Caco-2 cell assay[1].
KHK-IN-8 inhibits F1P production in HepG2 cells with an IC50 of 156 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3108075-72-2
-
Molecular Weight 447.45
-
Formula C22H24F3N5O2
-
SMILES
CN([C@H]1CCN(C2=NC(NC3=CC(CCC(O)=O)=CC=C3)=C(C#N)C(C(F)(F)F)=C2)C1)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)